TOP-N53: A Clinical Drug Candidate for the Treatment of Non-healing Wounds by Reto Naef, Hermann Tenor, Guido Koch

Get full text

Roflumilast-N-oxide induces surfactant protein expression in human alveolar epithelial cells type II. by Kerstin Höhne, Stephan J Schliessmann, Andreas Kirschbaum, Till Plönes, Joachim Müller-Quernheim, Hermann Tenor, Gernot Zissel

Get full text

Roflumilast N-oxide prevents cytokine secretion induced by cigarette smoke combined with LPS through JAK/STAT and ERK1/2 inhibition in airway epithelial cells. by Tatiana Victoni, Florence Gleonnec, Manuella Lanzetti, Hermann Tenor, Samuel Valença, Luis Cristovão Porto, Vincent Lagente, Elisabeth Boichot

Get full text

Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-α and chemokine production by human lung parenchyma. by Amparo Buenestado, Marie-Camille Chaumais, Stanislas Grassin-Delyle, Paul-André Risse, Emmanuel Naline, Elisabeth Longchampt, Hermann Tenor, Philippe Devillier

Get full text

Topical Wound Treatment with a Nitric Oxide-Releasing PDE5 Inhibitor Formulation Enhances Blood Perfusion and Promotes Healing in Mice by Maya Ben-Yehuda Greenwald, Yu-Hang Liu, Weiye Li, Paul Hiebert, Maria Zubair, Hermann Tenor, Tobias Braun, Reto Naef, Daniel Razansky, Sabine Werner

Get full text

Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist by Hélène Salvator, Hélène Salvator, Amparo Buenestado, Marion Brollo, Emmanuel Naline, Emmanuel Naline, Tatiana Victoni, Elisabeth Longchamp, Hermann Tenor, Stanislas Grassin-Delyle, Stanislas Grassin-Delyle, Philippe Devillier, Philippe Devillier

Get full text